This Study is About the Efficacy of Repetitive Peripheral Magnetic Stimulation on the Treatment of Shoulder Subluxation in Subacute Stroke Patients.

Launched by MAHIDOL UNIVERSITY · Nov 6, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a treatment called repetitive peripheral magnetic stimulation (rPMS) to see if it can help improve shoulder subluxation in patients who have had a stroke within the last six months. Shoulder subluxation is when the shoulder joint partially slips out of its normal position, which can happen after a stroke. The researchers want to find out if rPMS can reduce this problem and help patients regain better movement in their arms.

To participate in this study, individuals must be in the subacute phase of recovery from their first stroke and have noticeable shoulder subluxation. Participants will receive either real rPMS or a placebo (sham rPMS) for 20 minutes, five days a week, over two weeks, alongside a standard rehabilitation program. They will also have follow-up appointments to track their progress at various points after treatment. It’s important to note that some patients can't participate, including those with certain medical conditions or previous shoulder issues. This study aims to provide new insights into improving recovery for stroke patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subacute phase (seven days to six months) and first time of stroke patients
• • Shoulder subluxation that measured half of a fingerbreadth or more
• • Meet the criteria for admission to a comprehensive rehabilitation program
• • Medically stable
• • Intact skin on the hemiparetic arm
• Exclusion Criteria:
• • Patients with contraindication for magnetic stimulation; cardiac pacemakers, magnetic materials near the intended stimulation site
• • Patients with pregnancy
• • Patients with severe aphasia or severe cognitive impairment
• • Patients with previous shoulder pathology or limit shoulder function before stroke
• • Patients with unstable vital signs